Replimune Group, Inc. — Director's Dealing 2020

Dec 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-12-09

Reporting Person: Astley-Sparke Philip (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-09	Common Stock	S	600	$45.79	Disposed	1354697	Direct
2020-12-09	Common Stock	S	6025	$44.85	Disposed	1348672	Direct
2020-12-09	Common Stock	S	6459	$43.88	Disposed	1342213	Direct
2020-12-09	Common Stock	S	11116	$43.09	Disposed	1331097	Direct
2020-12-09	Common Stock	S	800	$42.03	Disposed	1330297	Direct
2020-12-10	Common Stock	S	5086	$43.72	Disposed	1325211	Direct
2020-12-10	Common Stock	S	16051	$42.99	Disposed	1309160	Direct
2020-12-10	Common Stock	S	3863	$42.39	Disposed	1305297	Direct

Footnotes

F1: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 6, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

F2: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.47 to $45.56. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.40 to $44.41. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.40 to $43.42. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F5: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.40 to $42.48. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F6: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.29 to $41.78. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F7: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.45 to $43.46. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F8: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.45 to $42.46. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F9: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.45 to $42.26. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F10: Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,305,297 shares of the Issuer's common stock. The reporting person also holds options to acquire 647,571 shares of the Issuer's common stock, 220,022 of which are exercisable as of the date hereof.